News Daily News Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER Michael O'Riordan December 12, 2025
News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News ESC 2025 ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF Todd Neale September 02, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Daily News Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients Caitlin E. Cox July 14, 2025
News Conference News EuroPCR 2025 OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI L.A. McKeown May 28, 2025
News Conference News EuroPCR 2025 Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data Yael L. Maxwell May 20, 2025
News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Daily News Lower Risk of Mortality for Shock Patients Transferred to Expert Centers Caitlin E. Cox March 17, 2025
News Conference News TCT 2024 Bleeding After MCS in DanGer Shock: When, Where, and What to Do? Caitlin E. Cox October 31, 2024
News Conference News TCT 2024 DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI Todd Neale October 29, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Daily News Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear Caitlin E. Cox July 03, 2024
News Daily News Risk of Death Remains Low a Decade After Primary PCI for STEMI Caitlin E. Cox June 18, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024